Invention Grant
- Patent Title: Radiolabeled prostate specific membrane antigen inhibitors
- Patent Title (中): 放射性标记的前列腺特异性膜抗原抑制剂
-
Application No.: US13566849Application Date: 2012-08-03
-
Publication No.: US08926944B2Publication Date: 2015-01-06
- Inventor: John W. Babich , Craig Zimmerman , John L. Joyal , Genliang Lu
- Applicant: John W. Babich , Craig Zimmerman , John L. Joyal , Genliang Lu
- Applicant Address: US MA Cambridge
- Assignee: Molecular Insight Pharmaceuticals
- Current Assignee: Molecular Insight Pharmaceuticals
- Current Assignee Address: US MA Cambridge
- Agency: Foley & Lardner LLP
- Agent Gilberto M. Villacorta; Jeffrey R. Lomprey
- Main IPC: A61K51/04
- IPC: A61K51/04 ; A61K49/00 ; C07F5/00 ; C07D257/02 ; C07D255/02
Abstract:
Compounds according to Formula I and Formula II are potent inhibitors of PSMA activity: The invention also provides pharmaceutical compositions of a complex of a radionuclide and a Formula I compound or a Formula II compound and methods of using the radionuclide complex of a Formula I compound or a Formula II compound for treating or diagnosis of a disease or a condition associated with PSMA activity.
Public/Granted literature
- US20130034494A1 RADIOLABELED PROSTATE SPECIFIC MEMBRANE ANTIGEN INHIBITORS Public/Granted day:2013-02-07
Information query
